Fig. 2: OMO-1 impacts tumor infiltrating neutrophils and immunosuppressive macrophages in a 4T1-based intraductal model. | npj Breast Cancer

Fig. 2: OMO-1 impacts tumor infiltrating neutrophils and immunosuppressive macrophages in a 4T1-based intraductal model.

From: OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer

Fig. 2

Immunohistochemistry for CD11b (pan-myeloid cells), CD163 (tumor-associated macrophages), Ly6G (neutrophils), and CD8a (cytotoxic T-cells) on paraffin sections of primary tumors from the different treatment groups at 39 days p.i. (n = 8; 2 slides per treatment group for each marker with 4 images per slide). Scale bars = 50 µm. Data are presented as the means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page